OpenURL Connection Search

Select item for more details and to access through your institution.

Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial
Published in:
Diabetes/Metabolism Research & Reviews, 2013, v. 29, n. 5, p. 417, doi. 10.1002/dmrr.2413
By:
- Mosenzon, O.;
- Raz, I.;
- Scirica, B. M.;
- Hirshberg, B.;
- Stahre, C. I.;
- Steg, P. G.;
- Davidson, J.;
- Ohman, P.;
- Price, D. L.;
- Frederich, B.;
- Udell, J. A.;
- Braunwald, E.;
- Bhatt, D. L.
Publication type:
Article
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
Published in:
2013
By:
- Mosenzon, O;
- Raz, I;
- Scirica, B M;
- Hirshberg, B;
- Stahre, C I;
- Steg, P G;
- Davidson, J;
- Ohman, P;
- Price, D L;
- Frederich, B;
- Udell, J A;
- Braunwald, E;
- Bhatt, D L
Publication type:
Journal Article
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Published in:
2000
By:
- Bhatt, Deepak L.;
- Topol, Eric J.;
- Bhatt, D L;
- Topol, E J
Publication type:
journal article
High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH registry.
Published in:
European Journal of Neurology, 2009, v. 16, n. 8, p. 902, doi. 10.1111/j.1468-1331.2009.02614.x
By:
- Aichner, F. T.;
- Topakian, R.;
- Alberts, M. J.;
- Bhatt, D. L.;
- Haring, H.-P.;
- Hill, M. D.;
- Montalescot, G.;
- Goto, S.;
- Touz, E.;
- Mas, J.-L.;
- Steg, P. G.;
- Röther, J.
Publication type:
Article
P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease.
Published in:
International Journal of Laboratory Hematology, 2012, v. 34, n. 5, p. 473, doi. 10.1111/j.1751-553X.2012.01420.x
By:
- Timur, A. A.;
- Murugesan, G.;
- Zhang, L.;
- Aung, P. P.;
- Barnard, J.;
- Wang, Q. K.;
- Gaussem, P.;
- Silverstein, R. L.;
- Bhatt, D. L.;
- Kottke-Marchant, K.
Publication type:
Article
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials.
Published in:
Internal Medicine Journal, 2002, v. 32, n. 7, p. 338, doi. 10.1046/j.1445-5994.2002.00226.x
By:
- Chew, D. P.;
- Bhatt, D. L.
Publication type:
Article
Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.
Published in:
Diabetes, Obesity & Metabolism, 2016, v. 18, n. 2, p. 186, doi. 10.1111/dom.12582
By:
- Leiter, L. A.;
- Teoh, H.;
- Mosenzon, O.;
- Cahn, A.;
- Hirshberg, B.;
- Stahre, C. A. M.;
- Hoekstra, J. B. L.;
- Alvarsson, M.;
- Im, K.;
- Scirica, B. M.;
- Bhatt, D. L.;
- Raz, I.
Publication type:
Article
Response to: 'baseline differences in SAVOR trial' - prespecified vs. post hoc analysis - a potential source of bias.
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1203, doi. 10.1111/dom.12579
By:
- Raz, I.;
- Cahn, A.;
- Mosenzon, O.;
- Scirica, B. M.;
- Bhatt, D. L.
Publication type:
Article
Impact of treatment with saxagliptin on glycaemic stability and β-cell function in the SAVOR-TIMI 53 study.
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 5, p. 487, doi. 10.1111/dom.12445
By:
- Leibowitz, G.;
- Cahn, A.;
- Bhatt, D. L.;
- Hirshberg, B.;
- Mosenzon, O.;
- Wei, C.;
- Jermendy, G.;
- Sheu, W. H.‐H.;
- Sendon, J. L.;
- Im, K.;
- Braunwald, E.;
- Scirica, B. M.;
- Raz, I.
Publication type:
Article
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
Published in:
Diabetes, Obesity & Metabolism, 2014, v. 16, n. 12, p. 1230, doi. 10.1111/dom.12376
By:
- Malin, S. K.;
- Bena, J.;
- Abood, B.;
- Pothier, C. E.;
- Bhatt, D. L.;
- Nissen, S.;
- Brethauer, S. A.;
- Schauer, P. R.;
- Kirwan, J. P.;
- Kashyap, S. R.
Publication type:
Article
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
Published in:
European Heart Journal, 2019, v. 40, n. 18, p. 1466, doi. 10.1093/eurheartj/ehy347
By:
- Fox, K A A;
- Eikelboom, J W;
- Anand, S S;
- Bhatt, D L;
- Bosch, J;
- Connolly, S J;
- Harrington, R A;
- Steg, P G;
- Yusuf, S
Publication type:
Article
Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects.
Published in:
Clinical Pharmacology & Therapeutics, 2011, v. 90, n. 2, p. 287, doi. 10.1038/clpt.2011.127
By:
- Simon, T.;
- Bhatt, D. L.;
- Bergougnan, L.;
- Farenc, C.;
- Pearson, K.;
- Perrin, L.;
- Vicaut, E.;
- LaCreta, F.;
- Hurbin, F.;
- Dubar, M.
Publication type:
Article
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
Published in:
International Journal of Obesity, 2014, v. 38, n. 3, p. 364, doi. 10.1038/ijo.2013.196
By:
- Malin, S K;
- Samat, A;
- Wolski, K;
- Abood, B;
- Pothier, C E;
- Bhatt, D L;
- Nissen, S;
- Brethauer, S A;
- Schauer, P R;
- Kirwan, J P;
- Kashyap, S R
Publication type:
Article
Economic implications of obesity among people with atherothrombotic disease.
Published in:
International Journal of Obesity, 2010, v. 34, n. 8, p. 1284, doi. 10.1038/ijo.2010.42
By:
- Ademi, Z.;
- Walls, H. L.;
- Peeters, A.;
- Liew, D.;
- Hollingsworth, B.;
- Stevenson, C.;
- Steg, Ph.-G.;
- Bhatt, D. L.;
- Reid, C. M.
Publication type:
Article
Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.
Published in:
Journal of Internal Medicine, 2010, v. 267, n. 6, p. 621, doi. 10.1111/j.1365-2796.2009.02198.x
By:
- Mechtouff, L.;
- Touzé, E.;
- Steg, P. G.;
- Ohman, E. M.;
- Goto, S.;
- Hirsch, A. T.;
- Röther, J.;
- Aichner, F. T.;
- Weimar, C.;
- Bhatt, D. L.;
- Alberts, M. J.;
- Mas, J.-L.
Publication type:
Article
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: Final follow-up of the randomised SYMPLICITY HTN-3 trial.
Published in:
Cardiology Research Review, 2022, n. 104, p. 6
By:
- D. L., Bhatt
Publication type:
Article
The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 3, p. 365, doi. 10.1111/apt.13260
By:
- Vardi, M.;
- Cryer, B. L.;
- Cohen, M.;
- Lanas, A.;
- Schnitzer, T. J.;
- Lapuerta, P.;
- Goldsmith, M. A.;
- Laine, L.;
- Doros, G.;
- Liu, Y.;
- McIntosh, A. I.;
- Cannon, C. P.;
- Bhatt, D. L.
Publication type:
Article
In at-risk patients with type 2 diabetes, saxagliptin and placebo did not differ for CV events.
Published in:
Annals of Internal Medicine, 2014, v. 160, n. 2, p. JC9
By:
- Bhatt, D. L.
Publication type:
Article
Cangrelor reduced ischemic PCI complications more than clopidogrel without increasing severe bleeding.
Published in:
Annals of Internal Medicine, 2013, v. 158, n. 12, p. JC5
By:
- Bhatt, D. L.;
- Riezebos, Robert K.;
- Verheugt, Freek W. A.
Publication type:
Article

Found: 19